4//SEC Filing
FIELDS HEIDI 4
Accession 0000950170-25-082453
CIK 0001783183other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:56 PM ET
Size
7.6 KB
Accession
0000950170-25-082453
Insider Transaction Report
Form 4
KUNZ HEIDI
Director
Transactions
- Award
Common Stock
2025-06-03+10,500→ 30,000 total - Award
Stock Option (Right to Buy)
2025-06-03+17,500→ 17,500 totalExercise: $4.95Exp: 2035-06-02→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001014330
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:56 PM ET
- Size
- 7.6 KB